Login

Davide Tinazzi (Energy) Interviewed by ItalyPost and auxiell | Davide Tinazzi - CEO of Energy SpA 00:10:00

Share On Facebook Share On Twitter

Davide Tinazzi is Chief Executive Officer at Energy SpA.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Key Differences Between Financial Advisors and Wealth Managers
00:10:00
Innovating User Experience and Shaping Tomorrow's Cities: Covivio's European Vision and Strategic Imperatives | Christophe Kullmann, CEO, Covivio Hotels SCA.
00:10:00
Transforming Mining Legacies: DRD's Focus on Tailings Retreatment and Sustainable Growth at One-to-One Mining Investment Conference
00:10:00
Everest Wealth Management: Secure Your Retirement with Guaranteed Growth
00:10:00
supports founders and CEOs from their early days through every stage of growth|Byron Deeter,Partner,Bessemer Venture Partners
00:10:00
Assessing Investment Potential in Southern Silver Exploration Corporation
00:10:00
There is plenty to do for Digia | Timo Levoranta, CEO, Digia OyjDIGIA:HEX
00:10:00
Nordic Nickel CEO Todd Ross Discusses Pulu Project and Growth Plans
00:10:00
Stephen Spencer, Managing Director at Houlihan Lokey, shares insights alongside the CEO of Capital Power on industry developments.
00:10:00
Glenn August, Oak Hill Advisors CEO, Discusses $5 Billion Credit Investment Strategy | Glenn August, CEO, Oak Hill Advisors.
00:10:00
Navigating Market Uncertainty: Insights and Strategies from Wealth Management | Dr. David Ashby, Co-Founders , Mustard Seed Wealth Management.
00:10:00
He is the CFO of 4iG among the best | Gellért Jászai, CEO, 4iG Nyrt4IG:BUD

© 2017 - Neuhu+